Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 45 (1), 122-128
- https://doi.org/10.1016/0090-1229(87)90118-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Regional suppression, therapy after onset and prevention of relapses in experimental allergic encephalomyelitis by mitoxantroneJournal of Neuroimmunology, 1986
- Studies of the effect of mitoxantrone on adjuvant induced arthritis in ratsClinical Immunology and Immunopathology, 1986
- Mitoxantrone: A New Anticancer Drug with Significant Clinical ActivityAnnals of Internal Medicine, 1986
- Relapsing experimental allergic encephalomyelitis an autoimmune model of multiple sclerosisSpringer Seminars in Immunopathology, 1985
- Suppression of experimental allergic encephalomyelitis by mitoxantroneClinical Immunology and Immunopathology, 1985
- Immunomodulation of relapsing experimental allergic encephalomyelitisNeurology, 1984
- Induction of alloreactive immunosuppression by 1,4-bis [(2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (CL 232,468)International Journal of Immunopharmacology, 1984
- Mitoxantrone (novantrone): a review of experimental and early clinical studiesCancer Treatment Reviews, 1983
- Delayed, relapsing experimental allergic encephalomyelitis in mice.The Journal of Immunology, 1981
- Experimental Allergic Encephalomyelitis and Autoimmune DiseaseAdvances in Immunology, 1966